DBVT — DBV Technologies S.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1613780 ·
France
Last close
$9.55
Market Cap
$600.20M
52W High
$26.18
52W Low
$9.36
ADV30
365,449
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -50,600,000 | -50,400,000 | 223,200,000 | 174,900,000 | 62,800,000 |
| Mar 2026 | 0 | — | -47,900,000 | -47,600,000 | 266,400,000 | 229,200,000 | 58,500,000 |
| Dec 2025 | 0 | — | -45,048,000 | -44,829,000 | 233,718,000 | 194,167,000 | 64,948,000 |
| Sep 2025 | 0 | — | -34,277,000 | -33,164,000 | 110,495,000 | 69,837,000 | 57,641,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-168,983,000
Investing CF
$-1,869,000
Financing CF
$248,182,000
CapEx
$-1,296,000
Dividends Paid
—
Buybacks
$-159,000
EPS Diluted TTM
$-3.90
As of
2026-07-19
Balance + Analyst (yfinance extras)
Retained Earnings
$-270,300,000
Inventory
—
Receivables
$17,300,000
ST Investments
—
EBIT TTM
$-177,825,000
Pretax Income TTM
$-175,219,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,036,000
EBITDA
$-174,762,000
Free Cash Flow
$-104,847,504
Enterprise Value
$534,118,976
Total Cash
$174,900,000
Total Debt
$7,700,000
Shares Out
62,848,497
Trailing EPS
$-3.50
Book Value
$2.71
ROE
-142.7%
ROA
-60.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -147,054,000 | -146,947,000 | 233,718,000 | 64,948,000 | 168,770,000 | -121,181,000 |
| Dec 2024 | 0 | -116,590,000 | -113,918,000 | 65,658,000 | 38,271,000 | 27,388,000 | -104,474,000 |
| Dec 2023 | 0 | -76,433,000 | -72,726,000 | 182,986,000 | 42,799,000 | 140,186,000 | -79,653,000 |
| Dec 2022 | 0 | -96,631,000 | -96,274,000 | 246,518,000 | 52,065,000 | 194,454,000 | -55,666,000 |
TTM Snapshot
Revenues TTM
$5,783,000
NetIncome TTM
$-167,468,000
OpCashFlow TTM
—
Assets (Latest)
$266,400,000
Forward EPS
$-0.53
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ETRA | Electra Therapeutics, Inc. | $573.69M | $9.14 | — |
| DNA | Ginkgo Bioworks Holdings, Inc. | $628.05M | $11.34 | — |
| PRME | Prime Medicine, Inc. | $649.33M | $3.58 | — |
| VALN | Valneva SE | $539.55M | $5.69 | — |
| RGNX | REGENXBIO Inc. | $534.05M | $8.09 | — |
News headlines (Yahoo Finance, 1h cache)
DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years
2026-09-29 22:29 · Yahoo
European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading
2026-09-14 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
2026-10-01 15:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
2026-10-06 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
2026-10-05 15:12 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading
2026-10-02 15:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
2026-09-30 15:19 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Lower in Thursday Trading
2026-09-24 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
2026-09-23 15:20 · Yahoo
European Equities Traded in the US as American Depositary Receipts Drop in Friday Trading
2026-09-18 15:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.